Table 2.
Endpoint | Number of events
|
3-year estimate (%) | 95% confidence interval (%) | |
---|---|---|---|---|
First 3 years | Total | |||
Freedom from progression | 20 | 26 | 73.0 | 62.9 to 83.1 |
Local-regional progression | 0 | 0 | 0.0 | Not applicable |
Distant metastasis | 5 | 11 | 6.8 | 2.5 to 14.0 |
Biochemical failure | 19 | 25 | 25.7 | 16.3 to 36.1 |
Overall survival | 1 | 3 | 98.6 | 96.0 to 100 |
Prostate cancer death | 0 | 2 | 0.0 | Not applicable |
Non-prostate-cancer death | 1 | 1 | 1.4 | 0.1 to 6.5 |